Per Gjorstrup received his MD and PhD in physiology from the University of Lund, Sweden, where he was associate professor of physiology before joining industry. He brings over 25 years of experience in research and development with pharmaceutical and biotechnology companies, most recently as Chief Medical Officer at Micromet, Munich, Germany. Earlier industry positions include Section Leader Pharmacology at Astra (Astra-Zeneca). He later held positions as Head of Immunotherapeutics at Pharmacia, Sweden; senior director for clinical development at Biogen. He has served as advisor to VC groups and start-up companies and has published extensively in leading scientific journals.